Back to Search
Start Over
Reduced maternal behavior caused by gestational stress is predictive of life span changes in risk-taking behavior and gene expression due to altering of the stress/anti-stress balance
- Source :
- Neurotoxicology, Neurotoxicology, 2018, Neurotoxicology, 66, pp.138-149. ⟨10.1016/j.neuro.2018.04.005⟩, Neurotoxicology, Vol. 66 (2018) pp. 138-149
- Publication Year :
- 2018
-
Abstract
- Exposure of the mother to adverse events during pregnancy is known to induce pathological programming of the HPA axis in the progeny, thereby increasing the vulnerability to neurobehavioral disorders. Maternal care plays a crucial role in the programming of the offspring, and oxytocin plays a key role in mother/pup interaction. Therefore, we investigated whether positive modulation of maternal behavior by activation of the oxytocinergic system could reverse the long-term alterations induced by perinatal stress (PRS; gestational restraint stress 3 times/day during the last ten days of gestation) on HPA axis activity, risk-taking behavior in the elevated-plus maze, hippocampal mGlu5 receptor and gene expression in Sprague-Dawley rats. Stressed and control unstressed dams were treated during the first postpartum week with an oxytocin receptor agonist, carbetocin (1 mg/kg, i.p.). Remarkably, reduction of maternal behavior was predictive of behavioral disturbances in PRS rats as well as of the impairment of the oxytocin and its receptor gene expression. Postpartum carbetocin corrected the reduction of maternal behavior induced by gestational stress as well as the impaired oxytocinergic system in the PRS progeny, which was associated with reduced risk-taking behavior. Moreover, postpartum carbetocin had an anti-stress effect on HPA axis activity in the adult PRS progeny and increased hippocampal mGlu5 receptor expression in aging. In conclusion, the activation of the oxytocinergic system in the early life plays a protective role against the programming effect by adverse experiences and could be considered as a novel and powerful potential therapeutic target for stress-related disorders. 66
- Subjects :
- 0301 basic medicine
Agonist
medicine.medical_specialty
medicine.drug_class
Offspring
Receptor expression
Receptor, Metabotropic Glutamate 5
[SDV]Life Sciences [q-bio]
Gene Expression
Gestational Age
[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics
Maternal behavior
Risk-taking behavior
Oxytocin receptor agonist
Transcriptomics
Early-Life stress
Hippocampus
Oxytocin
Rats, Sprague-Dawley
03 medical and health sciences
0302 clinical medicine
Risk-Taking
Internal medicine
medicine
early-life stress
hippocampus
maternal behavior
oxytocin receptor agonist
risk-taking behavior
transcriptomics
neuroscience (all)
toxicology
Animals
Receptor
Pregnancy
ddc:618
business.industry
General Neuroscience
Postpartum Period
medicine.disease
Oxytocin receptor
[CHIM.THEO]Chemical Sciences/Theoretical and/or physical chemistry
030104 developmental biology
Endocrinology
Receptors, Oxytocin
Carbetocin
Female
business
030217 neurology & neurosurgery
Stress, Psychological
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 18729711 and 0161813X
- Database :
- OpenAIRE
- Journal :
- Neurotoxicology, Neurotoxicology, 2018, Neurotoxicology, 66, pp.138-149. ⟨10.1016/j.neuro.2018.04.005⟩, Neurotoxicology, Vol. 66 (2018) pp. 138-149
- Accession number :
- edsair.doi.dedup.....5165bcedb0efee028869e592f9558e62